Related Experiment Video
Updated: May 25, 2026

10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
New technologies for influenza vaccines.
Philip R Dormitzer1, Theodore F Tsai, Giuseppe Del Giudice
1Novartis Vaccines and Diagnostics, Cambridge, MA, USA. philip.dormitzer@novartis.com
Human Vaccines & Immunotherapeutics
|January 19, 2012
Summary
Influenza vaccines have diverse formulations, including inactivated, live, and subunit types. Ongoing research aims to address challenges like evolving strains and pandemics with novel immunization strategies.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Influenza vaccines have been used since the 1930s, with unparalleled diversity in licensed products.
- Existing vaccines include inactivated, split, subunit, live attenuated, and adjuvanted formulations.
- Various administration routes (intramuscular, intradermal, intranasal) and production methods (egg, cell culture) exist.
Purpose of the Study:
- To review novel approaches in influenza immunization.
- To highlight active research and development in new influenza vaccine strategies.
Main Methods:
- This is a review article, synthesizing information from existing research.
- The review focuses on describing new and emerging influenza vaccine technologies.
Main Results:
- The diversity of influenza vaccine approaches is extensive, encompassing various antigen types, adjuvants, and delivery systems.
- Challenges such as co-circulating strains, antigenic drift, broad age targets, and pandemic threats necessitate continuous innovation.
Conclusions:
- The field of influenza immunization is dynamic, driven by the need to overcome persistent challenges.
- New research avenues are crucial for developing improved and next-generation influenza vaccines.
More Related Videos
Related Concept Videos
Vaccinations
Overview
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

